Biological agents in the treatment of Crohn's disease: a propensity score-matched analysis from the prospective Persistence Australian National IBD Cohort (PANIC3) study.

John David ChetwoodYanna KoAviv Pudipeddi Viraj Kariyawasam Sudarshan Paramsothy Rupert W L Leong

Published in: The American journal of gastroenterology (2024)

This large national prospective database with non-hierarchical prescribing of biological agents did not identify superior persistence of any agent in bio-naïve CD. However, for bio-experienced CD patients, persistence was greater with ustekinumab.

Keyphrases

end stage renal disease
quality improvement
ejection fraction
newly diagnosed
chronic kidney disease
primary care
adverse drug
nk cells
patient reported outcomes
electronic health record